Multiple Sclerosis Clinical Trials in Chicago

Showing 481-500 of 714 trials

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

NCT01023958

The primary objective of this trial is to evaluate the efficacy and safety of BI 6727 in patients with locally advanced, metastatic or recurrent urothelial cancer after failure of first line or adjuvant/neoadjuvant chemotherapy.

Neoplasms

Boehringer Ingelheim50 participantsStarted Nov 2009

Beverly Hills, California, United States • Los Angeles, California, United States • Miami, Florida, United States +18 more locations

COMPLETEDNA2.2 miles

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

NCT01071512

The long-term objective is to further establish the role of Tysabri in preventing neurological degeneration in multiple sclerosis (MS) and to establish powerful and efficient new markers for neurological degeneration in MS. The study intends to correlate cognition with two instruments and their measurements-MRI and OCT (optical coherence tomography).

Multiple Sclerosis

University of Chicago20 participantsStarted Apr 2010

Chicago, Illinois, United States

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

Multiple Sclerosis Trials in Other Cities

Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung

Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

ARI103094-Follow-Up Study for REDUCE Study Subjects

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Evolution® Biliary Stent System-Fully Covered

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Low-Cost Molecular Cervical Cancer Screening Study

Other Conditions in Chicago